Guidance On Outdoor Promotion Will Formalize "Traditional" Approach – FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
A draft guidance on outdoor promotion will formalize the Division of Drug Marketing, Advertising & Communications' "traditional" approach to reviewing the advertisements, Director Thomas Abrams said
You may also be interested in...
FDA Brief Summary Study Would Gauge Patient Perception Of Drug Riskiness
FDA publishes draft protocol for trial to assist in finalizing brief summary guidance. The 432-subject trial would gather patients' perceptions of eight advertisements for low- or high-risk products in four medical conditions.
FDA Brief Summary Study Would Gauge Patient Perception Of Drug Riskiness
FDA publishes draft protocol for trial to assist in finalizing brief summary guidance. The 432-subject trial would gather patients' perceptions of eight advertisements for low- or high-risk products in four medical conditions.
FDA Sees Jump In Number Of Warning Letters For Promotion In 2004
CDER's ad division issued 12 warning letters in 2004, "a 250%-300% increase over the typical yearly average," ad division Director Abrams says. FDA is prepared to "do whatever it takes" to get compliance in direct-to-consumer advertising, Abrams declares.